No abstract available
Keywords:
arthritis, rheumatoid; autoimmune diseases; autoimmunity; lupus erythematosus, systemic; spondylitis, ankylosing.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / therapeutic use*
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / drug therapy
-
Betacoronavirus
-
COVID-19
-
Coronavirus Infections / complications
-
Coronavirus Infections / mortality*
-
Coronavirus Infections / physiopathology
-
Female
-
Glucocorticoids / therapeutic use
-
Hospitalization / statistics & numerical data
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Intensive Care Units
-
Interleukin 1 Receptor Antagonist Protein / therapeutic use
-
Janus Kinase Inhibitors / therapeutic use
-
Male
-
Methotrexate / therapeutic use
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / mortality*
-
Pneumonia, Viral / physiopathology
-
Rheumatic Diseases / complications
-
Rheumatic Diseases / drug therapy*
-
Rituximab / therapeutic use
-
SARS-CoV-2
-
Spain
-
Spondylarthropathies / complications
-
Spondylarthropathies / drug therapy
-
Tumor Necrosis Factor Inhibitors / therapeutic use
Substances
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Glucocorticoids
-
Interleukin 1 Receptor Antagonist Protein
-
Janus Kinase Inhibitors
-
Tumor Necrosis Factor Inhibitors
-
Rituximab
-
Hydroxychloroquine
-
secukinumab
-
Methotrexate